Immunologic and neurodevelopmental susceptibilities of autism

NeuroToxicology

Volumn 29, Issue 3, 2008, Pages 532-545

  Pessah, Isaac N ^a   Seegal, Richard F ^b   Lein, Pamela J ^c   LaSalle, Janine ^d   Yee, Benjamin K ^e   Van De Water, Judy ^a,e   Berman, Robert F ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WADSWORTH CENTER   (United States)

^c ETH ZURICH   (Switzerland)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ADHD; Autism; Mercury; Neuroimmunology; Organochlorines; Organophosphate; Polychlorinated biphenyls

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AUTOANTIBODY; CATECHOLAMINE; DOPAMINE TRANSPORTER; ETHYLMERCURY DERIVATIVE; ORGANOPHOSPHATE; POLYBROMINATED DIPHENYL ETHER; POLYCHLORINATED BIPHENYL; THIOMERSAL; THYROID HORMONE; ANTIFUNGAL AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; CHOLINERGIC TRANSMISSION; COMORBIDITY; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIGENETICS; HEREDITY; HUMAN; IMMUNOPATHOLOGY; NERVE CELL DIFFERENTIATION; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; ADULT; ANIMAL; CHEMICALLY INDUCED DISORDER; FEMALE; IMMUNOLOGY; PATHOLOGY; POLLUTANT; PREGNANCY; PSYCHOLOGICAL ASPECT; REVIEW; RISK; STATISTICS;

ANIMALIA;

ADULT; ANIMALS; ANTIFUNGAL AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; AUTOANTIBODIES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; POLYCHLORINATED BIPHENYLS; PREGNANCY; RISK; THIMEROSAL;

EID: 44649103238     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2008.02.006     Document Type: Article

References (210)

1. Aman M.G., and Langworthy K.S. Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders. J Autism Dev Disord 30 (2000) 451-519
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders DMS-IV-TR (text revision) (2000), American Psychiatric Association, Washington, DC
3. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., and Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl- CpG-binding protein 2. Nat Genet 23 (1999) 185-188
4. Arndt T.L., Stodgell C.J., and Rodier P.M. The teratology of autism. Int J Dev Neurosci 23 (2005) 189-199
5. Ashley-Koch A.E., Mei H., Jaworski J., Ma D.Q., Ritchie M.D., Menold M.M., et al. An analysis paradigm for investigating multi-locus effects in complex disease: examination of three GABA receptor subunit genes on 15q11-q13 as risk factors for autistic disorder. Ann Hum Genet 70 (2006) 281-292
6. Ashwood P., and Van de Water J. Is autism an autoimmune disease?. Autoimmun Rev 3 (2004) 557-562
7. Ashwood P., Wills S., and Van de Water J. The immune response in autism: a new frontier for autism research. J Leukoc Biol 80 (2006) 1-15
8. Ausó E., Lavado-Autric R., Cuevas E., Escobar del Rey F., Morreale de Escobar G., and Berbel P. A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology 145 (2004) 4037-4047
9. Bailey A., Le Couteur A., Gottesman I., Bolton P., Simonoff E., Yuzda E., et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 25 (1995) 63-77
10. Barone Jr. S., Das K.P., Lassiter T.L., and White L.D. Vulnerable processes of nervous system development: a review of markers and methods. Neurotoxicology 21 (2000) 15-36
11. Belmonte M.K., and Bourgeron T. Fragile X syndrome and autism at the intersection of genetic and neural networks. Nat Neurosci 9 (2006) 1221-1225
12. Bemis J.C., and Seegal R.F. PCB-induced inhibition of the vesicular monoamine transporter predicts reductions in synaptosomal dopamine content. Toxicol Sci 80 (2004) 288-295
13. Berger-Sweeney J., and Hohmann C.F. Behavioral consequences of abnormal cortical development: insights into developmental disabilities. Behav Brain Res 86 (1997) 121-142
14. Berman R.F., Pessah I.N., Mouton P.R., Mav D., and Harry J. Low-level neonatal thimerosal exposure: further evaluation of altered neurotoxic potential in SJL mice. Toxicol Sci 101 (2008) 294-309
15. Bernard S., Enayati A., Roger H., Binstock T., and Redwood L. The role of mercury in the pathogenesis of autism. Mol Psychiatry 7 (2002) S42-S43
16. Berridge M.J. Calcium microdomains: organization and function. Cell Calcium 40 (2006) 405-412
17. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry 57 (2005) 1215-1220
18. Bittel D.C., Kibiryeva N., Talebizadeh Z., and Butler M.G. Microarray analysis of gene/transcript expression in Prader-Willi syndrome: deletion versus UPD. J Med Genet 40 (2003) 568-574
19. Bittel D.C., Kibiryeva N., Talebizadeh Z., Driscoll D.J., and Butler M.G. Microarray analysis of gene/transcript expression in Angelman syndrome: deletion versus UPD. Genomics 85 (2005) 85-91
20. Bloomquist J.R. Chloride channels as tools for developing selective insecticides. Arch Insect Biochem Physiol 54 (2003) 145-156
21. Braunschweig D., Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Croen L.A., et al. Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology 29 (2008) 226-231
22. Brown A.S. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 32 (2006) 200-202
23. Brown A.S., and Susser E.S. In utero infection and adult schizophrenia. Ment Retard Dev Disabil Res Rev 8 (2002) 51-57
24. Brunn H., Georgii S., and Prucha J. Polychlorinated biphenyls (PCB) in human adipose tissue. Z Lebensm Unters Forsch 190 (1990) 108-111
25. Burbacher T.M., Shen D.D., Liberato N., Grant K.S., Cernichiari E., and Clarkson T. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect 113 (2005) 1015-1021
26. Buxbaum J.D., Silverman J.M., Smith C.J., Greenberg D.A., Kilifarski M., Reichert J., et al. Association between a GABRB3 polymorphism and autism. Mol Psychiatry 7 (2002) 311-316
27. Cabanlit M., Wills S., Goines P., Ashwood P., and Van de Water J. Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann NY Acad Sci 1107 (2007) 92-103
28. Campbell D.B., Sutcliffe J.S., Ebert P.J., Militerni R., Bravaccio C., Trillo S., et al. A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci USA 103 (2006) 16834-16839
29. Carpenter D.O. Polychlorinated biphenyls (PCBs): routes of exposure and effects on human health. Rev Environ Health 21 (2006) 1-23
30. Chen L., Durkin K.A., and Casida J.E. Structural model for gamma-aminobutyric acid receptor noncompetitive antagonist binding: widely diverse structures fit the same site. Proc Natl Acad Sci USA 103 (2006) 5185-5190
31. Cheon K.A., Ryu Y.H., Kim Y.K., Namkoong K., Kim C.H., and Lee J.D. Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder. Eur J Nucl Med Mol Imaging 30 (2003) 306-311
32. Cinca I., Dumitrescu I., Onaca P., Serbanescu A., and Nestorescu B. Accidental ethyl mercury poisoning with nervous system, skeletal muscle,and myocardium injury. J Neurol Neurosurg Psych 43 (1980) 143-149
33. Clarkson T.W., Magos L., and Myers G.J. The toxicology of mercury-Current exposures and clinical manifestations. N Engl J Med 349 (2003) 1731-1737
34. Clarkson T.W., and Magos L. The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 36 (2006) 609-662
35. Cohly H.H., and Panja A. Immunological findings in autism. Int Rev Neurobiol 71 (2005) 317-341
36. Cole L.M., and Casida J.E. Polychlorocycloalkane insecticide-induced convulsions in mice in relation to disruption of the GABA-regulated chloride ionophore. Life Sci 39 (1986) 1855-1862
37. Connolly A.M., Chez M.G., Pestronk A., Arnold S.T., Mehta S., and Deuel R.K. Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J Pediatr 134 (1999) 607-613
38. Connolly A.M., Chez M., Streif E.M., Keeling R.M., Golumbek P.T., Kwon J.M., et al. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol Psychiatry 59 (2006) 354-363
39. Crawley J.N. Designing mouse behavioral tasks relevant to autistic like behaviors. Ment Retard Dev Disabil Res Rev 10 (2004) 248-258
40. Crofton K.M., Kodavanti P.R., Derr-Yellin E.C., Casey A.C., and Kehn L.S. PCBs, thyroid hormones, and ototoxicity in rats: cross-fostering experiments demonstrate the impact of postnatal lactation exposure. Toxicol Sci 57 (2000) 131-140
41. Culiat C.T., Stubbs L.J., Montgomery C.S., Russell L.B., and Rinchik E.M. Phenotypic consequences of deletion of the gamma 3, alpha 5, or beta 3 subunit of the type A gamma-aminobutyric acid receptor in mice. Proc Natl Acad Sci USA 91 (1994) 2815-2818
42. Cunningham C., Campion S., Teeling J., Felton L., and Perry V.H. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav Immun 21 (2007) 490-502
43. Dalton P., Deacon R., Blamire A., Pike M., McKinlay I., Stein J., et al. Maternal neuronal antibodies associated with autism and a language disorder. Ann Neurol 53 (2003) 533-537
44. D'Amelio M., Ricci I., Sacco R., Liu X., D'Agruma L., Muscarella L.A., et al. Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene-environment interactions. Mol Psychiatry 10 (2005) 1006-1016
45. Damluji S. Mercurial poisoning with the fungicide granosan. J Fac Med Baghdad 4 (1962) 83-103
46. Davidson P.W., Myers G.J., and Weiss B. Mercurychild development outcomes. Pediatrics 113 (2004) 1023-1029
47. Davids E., Zhang K., Tarazi F.I., and Baldessarini R.J. Animal models of attention-deficit hyperactivity disorder. Brain Res Rev 42 (2003) 1-21
48. DeCaprio A.P., Johnson G.W., Tarbell A.M., Carpenter D.O., Chiarenzelli J.R., Morse G.S., et al. Polychlorinated biphenyl (PCB) exposure assessment by multivariate statistical analysis of serum congener profiles in an adult Native American population. Environ Res 98 (2005) 284-302
49. DeLorey T.M., Handforth A., Anagnostaras S.G., Homanics G.E., Minassian B.A., Asatourian A., et al. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J Neurosci 18 (1998) 8505-8514
50. DiCicco-Bloom E., Lord C., Zwaigenbaum L., Courchesne E., Dager S.R., Schmitz C., et al. The developmental neurobiology of autism spectrum disorder. J Neurosci 26 (2006) 6897-6906
51. Dulce Madeira M., Pereira A., Cadete-Leite A., and Paula-Barbosa M.M. Estimates of volumes and pyramidal cell numbers in the prelimbic subarea of the prefrontal cortex in experimental hypothyroid rats. J Anat 171 (1990) 41-56
52. Egger G., Liang G., Aparicio A., and Jones P.A. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429 (2004) 457-463
53. Eskenazi B., Marks A.R., Bradman A., Harley K., Barr D.B., Johnson C., et al. Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children. Environ Health Perspect 115 (2007) 792-798
54. Evans I.M., Sinha A.K., Pickard M.R., Edwards P.R., and Leonard A.J. Maternal hypothyroxinemia disrupts neurotransmitter metabolic enzymes in developing brain. J Endocrinol 161 (1999) 273-279
55. Fatemi S.H. Neuropsychiatric disorders and infection (2005), Taylor & Francis, London
56. Fiumara A., Sciotto A., Barone R., D'Asero G., Munda S., Parano E., et al. Peripheral lymphocyte subsets and other immune aspects in Rett syndrome. Pediatr Neurol 21 (1999) 619-621
57. Folstein S.E., and Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet 2 (2001) 943-955
58. Fortier M.E., Kent S., Ashdown H., Poole S., Boksa P., and Luheshi G.N. The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 287 (2004) R759-R766
59. Fraga M.F., Ballestar E., Paz M.F., Ropero S., Setien F., Ballestar M.L., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102 (2005) 10604-10609
60. Gabriel J.M., Higgins M.J., Gebuhr T.C., Shows T.B., Saitoh S., and Nicholls R.D. A model system to study genomic imprinting of human genes. Proc Natl Acad Sci USA 95 (1998) 14857-14862
61. Gafni J., Wong P.W., and Pessah I.N. Non-coplanar 2,2′,3,5′,6-pentachlorobiphenyl (PCB 95) amplifies ionotropic glutamate receptor signaling in embryonic cerebellar granule neurons by a mechanism involving ryanodine receptors. Toxicol Sci 77 (2004) 72-82
62. Gainetdinov R.R., and Caron M.G. Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol 43 (2003) 261-284
63. Garty B.Z., Ludomirsky A., Danon Y.L., Peter J.B., and Douglas S.D. Placental transfer of immunoglobulin G subclasses. Clin Diagn Lab Immunol 1 (1994) 667-669
64. Geschwind D.H., and Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol 17 (2007) 103-111
65. Gilmore J.H., and Jarskog L.F. Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia. Schizophr Res 24 (1997) 365-367
66. Gilmore J.H., Jarskog L.F., and Vadlamudi S. Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat. J Neuroimmunol 159 (2005) 106-112
67. Goldman L.S., Genel M., Bezman R.J., and Slanetz P.J. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA 279 (1998) 1100-1107
68. Hagmar L. Polychlorinated biphenyls and thyroid status in humans: a review. Thyroid 13 (2003) 1021-1028
69. Hany J., Lilienthal H., Roth-Harer A., Ostendorp G., Heinzow B., and Winneke G. Behavioral effects following single and combined maternal exposure to PCB 77 (3,4,3′,4′-tetrachlorobiphenyl) and PCB 47 (2,4,2′,4′- tetrachlorobiphenyl) in rats. Neurotoxicol Teratol 21 (1999) 147-156
70. Harry G.J., Harris M.W., and Burka L.T. Mercury concentrations in brain and kidney following ethylmercury, methylmercury and thimerosal administration to neonatal mice. Toxicol Lett 154 (2004) 183-189
71. Harris N.L., Spoerri I., Schopfer J.F., Nembrini C., Merky P., Massacand J., et al. Mechanisms of neonatal mucosal antibody protection. J Immunol 177 (2006) 6256-6262
72. Hauser P., Zametkin A.J., Martinez P., et al. Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med 328 (1993) 997-1001
73. Havarinasab S., Haggqvist B., Bjorn E., Pollard K.M., and Hultman P. Immunosuppressive and autoimmune effects of thimerosal in mice. Toxicol Appl Pharmacol 204 (2005) 109-121
74. Havarinasab S., and Hultman P. Organic mercury compounds and autoimmunity. Autoimmun Rev 4 (2005) 270-275
75. Heiser P., Friedel S., Dempfle A., et al. Molecular genetic aspects of attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev 28 (2004) 625-641
76. Hendrich B., and Bickmore W. Human diseases with underlying defects in chromatin structure and modification. Hum Mol Genet 10 (2001) 2233-2242
77. Hertz-Picciotto I., Croen L.A., Hansen R., Jones C.R., van de Water J., and Pessah I.N. The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect 114 (2006) 1119-1125
78. Himelstein J., Schulz K.P., Newcorn J.H., and Halperin J.M. The neurobiology of attention-deficit hyperactivity disorder. Front Biosci 5 (2000) 461-478
79. Hitchins M.P., Rickard S., Dhalla F., De Vries B.B., Winter R., Pembrey M.E., et al. Investigation of UBE3A and MECP2 in Angelman syndrome (AS) and patients with features of AS. Am J Med Genet 125A (2004) 167-172
80. Hogart A., Nagarajan R.P., Patzel K.A., Yasui D.H., and Lasalle J.M. 15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders. Hum Mol Genet 16 (2007) 691-703
81. Homanics G.E., DeLorey T.M., Firestone L.L., Quinlan J.J., Handforth A., Harrison N.L., et al. Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci USA 94 (1997) 4143-4148
82. Horike S., Cai S., Miyano M., Cheng J.F., and Kohwi-Shigematsu T. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 37 (2005) 31-40
83. Hornig M., Chian D., and Lipkin W.I. Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol Psychiatry 9 (2004) 833-845
84. Howard A.S., Fitzpatrick R., Pessah I., Kostyniak P., and Lein P.J. Polychlorinated biphenyls induce caspase-dependent cell death in cultured embryonic rat hippocampal but not cortical neurons via activation of the ryanodine receptor. Toxicol Appl Pharmacol 190 1 (2003) 72-86
85. Hultman P., and Hansson-Georgiadis H. Methyl mercury-induced autoimmunity in mice. Toxicol Appl Pharmacol 154 (1999) 203-211
86. Humphrey H.E., Gardiner J.C., Pandya J.R., Sweeney A.M., Gasior D.M., McCaffrey R.J., et al. PCB congener profile in the serum of humans consuming Great Lakes fish. Environ Health Perspect 108 (2000) 167-172
87. Huttenlocher P.R. Dendritic and synaptic pathology in mental retardation. Pediatr Neurol 7 (1991) 79-85
88. Jacobson J.L., and Jacobson S.W. Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N Engl J Med 335 (1996) 783-789
89. Jacobson J.L., and Jacobson S.W. Prenatal exposure to polychlorinated biphenyls and attention at school age. J Pediatr 143 (2003) 780-788
90. Jagadha V., and Becker L.E. Dendritic pathology: an overview of Golgi studies in man. Can J Neurol Sci 16 (1989) 41-50
91. Jameson R.R., Seidler F.J., and Slotkin T.A. Nonenzymatic functions of acetylcholinesterase splice variants in the developmental neurotoxicity of organophosphates: chlorpyrifos, chlorpyrifos oxon, and diazinon. Environ Health Perspect 115 (2007) 65-70
92. Jyonouchi H., Geng L., Ruby A., and Zimmerman-Bier B. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 51 (2005) 77-85
93. Kapfhammer J.P. Cellular and molecular control of dendritic growth and development of cerebellar Purkinje cells. Prog Histochem Cytochem 39 (2004) 131-182
94. Kenet T., Froemcke R., Schreiner C., Pessah I.N., and Merzenich M.M. Abnormal auditory cortex development in PCB exposed rats. Proc Natl Acad Sci USA 104 (2007) 7646-7651
95. Kodavanti P.R.S. Neurotoxicity of persistent organic pollutants: possible mode(s) of action and further considerations. Dose Response 3 (2005) 273-275
96. Krey J.F., and Dolmetsch R.E. Molecular mechanisms of autism: a possible role for Ca2+ signaling. Curr Opin Neurobiol 17 (2007) 112-119
97. Lalande M., and Calciano M.A. Molecular epigenetics of Angelman syndrome. Cell Mol Life Sci 64 (2007) 947-960
98. Lamb J.A., Moore J., Bailey A., and Monaco A.P. Autism: recent molecular genetic advances. Hum Mol Genet 9 (2000) 861-868
99. Lawrence L.J., and Casida J.E. Interactions of lindane, toxaphene and cyclodienes with brain-specific t-butylbicyclophosphorothionate receptor. Life Sci 35 (1984) 171-178
100. Lee M., Martin-Ruiz C., Graham A., Court J., Jaros E., Perry R., et al. Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 125 (2002) 1483-1495
101. Lohmann C., Finski A., and Bonhoeffer T. Local calcium transients regulate the spontaneous motility of dendritic filopodia. Nat Neurosci 8 (2005) 305-312
102. Lord C., Cook E.H., Leventhal B.L., and Amaral D.G. Autism spectrum disorders. Neuron 28 (2000) 355-363
103. Lord C., Risi S., Lambrecht L., Cook Jr. E.H., Leventhal B.L., DiLavore P.C., et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30 (2000) 205-223
104. Lu J., Karadsheh M., and Delpire E. Developmental regulation of the neuronal-specific isoform of K-Cl cotransporter KCC2 in postnatal rat brains. J Neurobiol 39 (1999) 558-568
105. Lyons H.R., Land M.B., Gibbs T.T., and Farb D.H. Distinct signal transduction pathways for GABA-induced GABA(A) receptor down-regulation and uncoupling in neuronal culture: a role for voltage-gated calcium channels. J Neurochem 78 (2001) 1114-1126
106. Ma D.Q., Whitehead P.L., Menold M.M., Martin E.R., Ashley-Koch A.E., Mei H., et al. Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. Am J Hum Genet 77 (2005) 377-388
107. Madras B.K., Miller G.M., and Fischman A.J. The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry 57 (2005) 1397-1409
108. Magos L. Neurotoxic character of thimerosal and the allometric extrapolation of adult clearance half-time to infants. J Appl Toxicol 23 (2003) 263-269
109. Magos L., Brown A.W., Sparrow S., Bailey E., Snowden R.T., and Skipp W.R. The comparative toxicology of ethyl- and methylmercury. Arch Toxicol 57 (1985) 260-267
110. Mariussen E., and Fonnum F. The effect of polychlorinated biphenyls on the high affinity uptake of the neurotransmitters dopamine, serotonin, glutamate and GABA, into rat brain synaptosomes. Toxicology 159 (2001) 11-21
111. Mariussen E., and Fonnum F. Neurochemical targets and behavioral effects of organohalogen compounds: an update. Crit Rev Toxicol 36 (2006) 253-289
112. Martin E.R., Menold M.M., Wolpert C.M., Bass M.P., Donnelly S.L., Ravan S.A., et al. Analysis of linkage disequilibrium in gamma-aminobutyric acid receptor subunit genes in autistic disorder. Am J Med Genet 96 (2000) 43-48
113. Martin-Ruiz C.M., Lee M., Perry R.H., Baumann M., Court J.A., and Perry E.K. Molecular analysis of nicotinic receptor expression in autism. Brain Res Mol Brain Res 123 (2004) 81-90
114. McGough J.J. Attention-deficit/hyperactivity disorder pharmacogenomics. Biol Psychiatry 57 (2005) 1367-1373
115. Meguro M., Mitsuya K., Sui H., Shigenami K., Kugoh H., Nakao M., et al. Evidence for uniparental, paternal expression of the human GABAA receptor subunit genes, using microcell-mediated chromosome transfer. Hum Mol Genet 6 (1997) 2127-2133
116. Menold M.M., Shao Y., Wolpert C.M., Donnelly S.L., Raiford K.L., Martin E.R., et al. Association analysis of chromosome 15 GABAA receptor subunit genes in autistic disorder. J Neurogenet 15 (2001) 245-259
117. Meyer U., Feldon J., Schedlowski M., and Yee B.K. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 29 (2005) 913-947
118. Meyer U., Feldon J., Schedlowski M., and Yee B.K. Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav Immun 20 (2006) 378-388
119. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 26 (2006) 4752-4762
120. Meyer U., Schwendener S., Feldon J., and Yee B.K. Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp Brain Res 173 (2006) 243-257
121. Meyer U., Yee B.K., and Feldon J. The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?. Neuroscientist 13 (2007) 241-256
122. Meyer U., Nyffeler M., Schwendener S., Knuesel I., Yee B.K., and Feldon J. Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 33 (2008) 441-456
123. Meyer U., Murray P.J., Urwyler A., Yee B.K., Schedlowski M., and Feldon J. Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signalling. Mol Psychiatry 13 (2008) 208-221
124. Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development. Brain Behav Immun; in press.
125. Michels G., and Moss S.J. GABAA receptors: properties and trafficking. Crit Rev Biochem Mol Biol 42 (2007) 3-14
126. Minassian B.A., DeLorey T.M., Olsen R.W., Philippart M., Bronstein Y., Zhang Q., et al. Angelman syndrome: correlations between epilepsy phenotypes and genotypes. Ann Neurol 43 (1998) 485-493
127. Molloy C.A., Morrow A.L., Meinzen-Derr J., Schleifer K., Dienger K., Manning-Courtney P., et al. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 172 (2006) 198-205
128. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683-765
129. Muhle R., Trentacoste S.V., and Rapin I. The genetics of autism. Pediatrics 113 (2004) e472-e486
130. Muller R.A. The study of autism as a distributed disorder. Ment Retard Dev Disabil Res Rev 13 (2007) 85-95
131. Murray P.J. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol 6 (2006) 379-386
132. Myers G.J., and Davidson P.W. Does methylmercury have a role in causing developmental disabilities in children?. Environ Health Perspect 108 (2000) 413-420
133. Nicholls R.D., Gottlieb W., Russell L.B., Davda M., Horsthemke B., and Rinchik E.M. Evaluation of potential models for imprinted and nonimprinted components of human chromosome 15q11-q13 syndromes by fine-structure homology mapping in the mouse. Proc Natl Acad Sci USA 90 (1993) 2050-2054
134. Nicholson J.L., and Altman J. Synaptogenesis in the rat cerebellum: effects of early hypo- and hyperthyroidism. Science 176 (1972) 530-532
135. Park J.S., Linderholm L., Charles M.J., Athanasiadou M., Petrik J., Kocan A., et al. Polychlorinated biphenyls and their hydroxylated metabolites (OH-PCBS) in pregnant women from eastern Slovakia. Environ Health Perspect 115 (2007) 20-27
136. Pasca S.P., Nemes B., Vlase L., Gagyi C.E., Dronca E., Miu A.C., et al. High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism. Life Sci 78 (2006) 2244-2248
137. Patterson P.H. Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr Opin Neurobiol 12 (2002) 115-118
138. Patterson P.H. Neuroscience. Maternal effects on schizophrenia risk. Science 318 (2007) 576-577
139. Peltier J., O'neill A., and Schaffer D.V. PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation. Dev Neurobiol 67 (2007) 1348-1361
140. Pennington B.F. Toward a new neuropsychological model of attention-deficit/hyperactivity disorder: subtypes and multiple deficits. Biol Psychiatry 57 (2005) 1221-1223
141. Perry E.K., Lee M.L., Martin-Ruiz C.M., et al. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry 158 (2001) 1058-1066
142. Pessah I.N., and Lein P.J. Evidence for environmental susceptibility in autism. What we need to know about gene × environment interactions. In: Zimmerman A.W. (Ed). Autism: current theories and evidence (2008), Humana Press
143. Pessah I.N., and Wong P.W. Etiology of PCB neurotoxicity: from molecules to cellular dysfunction. In: Robertson L., and Hansen L. (Eds). Progress in polychlorinated biphenyl toxicology (2001), Academic Press, New York, NY 179-184
144. 2+ channel complex type 1 (RyR1). Chem Res Toxicol 19 (2006) 92-101
145. Philippart M. Rett and Angelman's syndromes: models of arrested development. Pediatr Neurol 25 (2001) 288-294
146. Pichichero M.E., Cernichiari E., Lopreiato J., and Treanor J. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study. Lancet 360 (2002) 1737-1741
147. Pope C.N. Organophosphorus pesticides: do they all have the same mechanism of toxicity?. J Toxicol Environ Health B Crit Rev 2 (1999) 161-181
148. Rami A., Patel A.J., and Rabie A. Thyroid hormone and development of the rat hippocampus: morphological alterations in granule and pyramidal cells. Neuroscience 19 (1986) 1217-1226
149. Redmond L., and Ghosh A. Regulation of dendritic development by calcium signalling. Cell Calcium 37 (2005) 411-416
150. Ricceri L., Venerosi A., Capone F., Cometa M.F., Lorenzini P., Fortuna S., et al. Developmental neurotoxicity of organophosphorous pesticides: fetal and neonatal exposure to chlorpyrifos alters sex-specific behaviors at adulthood in mice. Toxicol Sci 93 (2006) 105-113
151. Ricceri L., Moles A., and Crawley J. Behavioral phenotyping of mouse models of neurodevelopmental disorders: Relevant social behaviorpatterns across the life span. Behav Brain Res 176 (2007) 40-52
152. Roberts EM, English PB, Grether JK, Windham GC, Somberg L, Wolff C. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Env Health Perspect 2007; [Epub ahead of print].
153. Roegge C.S., Wang V.C., Powers B.E., Klintsova A.Y., Villareal S., Greenough W.T., et al. Motor impairment in rats exposed to PCBs and methylmercury during early development. Toxicol Sci 77 (2004) 315-324
154. Rubenstein J.L., and Merzenich M.M. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2 (2003) 255-267
155. Ruiz-Marcos A., Cartagena-Abella P., Martinez-Galan J.R., Calvo R., Morreale de Escobar G., and Escobar del Rey F. Thyroxine treatment and the recovery of pyramidal cells of the cerebral cortex from changes induced by juvenile-onset hypothyroidism. J Neurobiol 25 (1994) 808-818
156. Russell V.A. Dopamine hypofunction possibility results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder-the spontaneously hypertensive rat. Neurosci Biobehav Rev 27 (2003) 671-682
157. Sagvolden T., Russell V.A., Aase H., Johansen E.B., and Farshbaf M. Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 57 (2005) 1239-1247
158. Samaco R.C., Hogart A., and LaSalle J.M. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet 14 (2005) 483-492
159. Sammelson R.E., Caboni P., Durkin K.A., and Casida J.E. GABA receptor antagonists and insecticides: common structural features of 4-alkyl-1-phenylpyrazoles and 4-alkyl-1-phenyltrioxabicyclooctanes. Bioorg Med Chem 12 (2004) 3345-3355
160. Schantz S.L., Widholm J.J., and Rice D.C. Effects of PCB exposure on neuropsychological function in children. Environ Health Perspect 111 (2003) 357-576
161. Schroer R.J., Phelan M.C., Michaelis R.C., Crawford E.C., Skinner S.A., Cuccaro M., et al. Autism and maternally derived aberrations of chromosome 15q. Am J Med Genet 76 (1998) 327-336
162. 2+/cAMP response element binding protein in cultured neurons. Toxicol Appl Pharmacol 182 (2002) 176-185
163. Seegal R.F. Epidemiological and laboratory evidence of PCB-induced neurotoxicity. Crit Rev Toxicol 26 (1996) 709-737
164. Seegal R.F., Bush B., and Brosch K.O. Comparison of effects of Aroclors 1016 and 1260 on nonhuman primate catecholamine function. Toxicology 66 (1991) 145-163
165. Seegal R.F., Brosch K.O., and Okoniewski R.J. Effects of in utero and lactational exposure of the laboratory rat to 2,4,2′,4′- and 3,4,3′,4′-tetrachlorobiphenyl on dopamine function. Toxicol Appl Pharmacol 146 (1997) 95-103
166. Seegal R.F., Okoniewski R.J., Brosch K.O., and Bemis J.C. Polychlorinated biphenyls alter extraneuronal but not tissue dopamine concentrations in adult rat striatum: an in vivo microdialysis study. Environ Health Perspect 110 (2002) 1113-1117
167. Seidman L.J., Valera E.M., and Makris N. Structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry 57 (2005) 1263-1272
168. Shain W., Bush B., and Seegal R.F. Neurotoxicity of polychlorinated biphenyls: structure-activity relationship of individual congeners. Toxicol Appl Pharmacol 111 (1991) 33-42
169. Simister N.E. Placental transport of immunoglobulin G. Vaccine 21 (2003) 3365-3369
170. Singh V.K., and Rivas W.H. Prevalence of serum antibodies to caudate nucleus in autistic children. Neurosci Lett 355 (2004) 53-56
171. Singh V.K., Warren R.P., Odell J.D., Warren W.L., and Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun 7 (1993) 97-103
172. Singh V.K., Singh E.A., and Warren R.P. Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation. Biol Psychiatry 41 (1997) 753-755
173. Singh V.K., Warren R., Averett R., and Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol 17 (1997) 88-90
174. Singh V.K., Lin S.X., Newell E., and Nelson C. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. J Biomed Sci 9 (2002) 359-364
175. Slotkin T.A., Seidler F.J., and Fumagalli F. Exposure to organophosphates reduces the expression of neurotrophic factors in neonatal rat brain regions: similarities and differences in the effects of chlorpyrifos and diazinon on the fibroblast growth factor superfamily. Environ Health Perspect 115 (2007) 909-916
176. Slotkin T.A., MacKillop E.A., Ryde I.T., Tate C.A., and Seidler F.J. Screening for developmental neurotoxicity using PC12 cells: comparisons of organophosphates with a carbamate, an organochlorine, and divalent nickel. Environ Health Perspect 115 (2007) 93-101
177. Solanto M.V. Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav Brain Res 130 (2002) 65-71
178. Splawski I., Timothy K.W., Sharpe L.M., Decher N., Kumar P., Bloise R., et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119 (2004) 19-31
179. Stachowiak M.K., Fang X., Myers J.M., Dunham S.M., Berezney R., Maher P.A., et al. Integrative nuclear FGFR1 signaling (INFS) as a part of a universal "feed-forward-and-gate" signaling module that controls cell growth and differentiation. J Cell Biochem 90 (2003) 662-691
180. Stajich G.V., Lopez G.P., Harry S.W., and Sexson W.R. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. J Pediatr 136 (2000) 679-681
181. Stein M.A., and Weiss R.E. Thyroid function tests and neurocognitive functioning in children referred for attention deficit/hyperactivity disorder. Psychoneuroendocrinology 28 (2003) 304-316
182. Stein M.A., Weiss R.E., and Refetoff S. Neurocognitive characteristics of individuals with resistance to thyroid hormone: comparisons with individuals with attention-deficit hyperactivity disorder. Dev Behav Pediatr 16 (1995) 406-411
183. Stellman S.D., Djordjevic M.V., Muscat J.E., Gong L., Bernstein D., Citron M.L., et al. Relative abundance of organochlorine pesticides and polychlorinated biphenyls in adipose tissue and serum of women in Long Island, New York. Cancer Epidemiol Biomarkers Prev 7 (1998) 489-496
184. Stewart P., Reihman J., Gump B., Lonky E., Darvill T., and Pagano J. Response inhibition at 8 and 9 1/2 years of age in children prenatally exposed to PCBs. Neurotoxicol Teratol 27 (2005) 771-780
185. In: Stratton K.G.A., and McCormick M.C. (Eds). Immunization safety review: thimerosal-containing vaccines and neurodevelopmental disorders (2001), Institute of Medicine, N.A. Press, Washington, D.C
186. Suzuki T., Takemoto T., Kashiwazaki H., and Miyama T. Metabolic fate of ethylmercury salts in man and animal. In: Miller M.W., and Clarkson T.W. (Eds). Mercury, Mercurials and Mercaptans (1973), Charles C. Thomas, Springfield, IL 2009-2040
187. Thatcher K.N., Peddada S., Yasui D.H., and Lasalle J.M. Homologous pairing of 15q11-13 imprinted domains in brain is developmentally regulated but deficient in Rett and autism samples. Hum Mol Genet 14 (2005) 785-797
188. Thompson W.W., Price C., Goodson B., Shay D.K., Benson P., Hinrichsen V.L., et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 357 (2007) 1281-1292
189. Todd R.D., Hickok J.M., Anderson G.M., and Cohen D.J. Antibrain antibodies in infantile autism. Biol Psychiatry 23 (1988) 644-647
190. Trikalinos T.A., Karvouni A., Zintzaras E., Ylisaukko-Oja T., Peltonen L., Jarvela I., et al. A heterogeneity-based genome search meta-analysis for autism-spectrum disorders. Mol Psychiatry 11 (2005) 29-36
191. Uylings H.B., van Pelt J., Parnavelas J.G., and Ruiz-Marcos A. Geometrical and topological characteristics in the dendritic development of cortical pyramidal and non-pyramidal neurons. Prog Brain Res 102 (1994) 109-123
192. van Gent T., Heijnen C.J., and Treffers P.D. Autism and the immune system. J Child Psychiatry Allied Disc 38 (1997) 337-349
193. Viggiano D., Vallone D., and Sadile A. Dysfunctions in dopamine systems and ADHD: evidence from animals and modeling. Neural Plast 11 (2004) 97-114
194. Vincent J.B., Horike S.I., Choufani S., Paterson A.D., Roberts W., Szatmari P., et al. An inversion inv(4)(p12-p15.3) in autistic siblings implicates the 4p GABA receptor gene cluster. J Med Genet 43 (2006) 429-434
195. Volkmar F.R., and Pauls D. Autism. Lancet 362 (2003) 1133-1141
196. Warren R.P., Foster A., and Margaretten N.C. Reduced natural killer cell activity in autism. J Am Acad Child Adolesc Psychiatry 26 (1987) 333-335
197. Warren R.P., Yonk L.J., Burger R.A., Cole P., Odell J.D., Warren W.L., et al. Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism. Immunol Invest 19 (1990) 245-251
198. Watanabe Y., Fujita M., Ito Y., Okada T., Kusuoka H., and Nishimura T. Brain dopamine transporter in spontaneously hypertensive rats. J Nucl Med 38 (1997) 470-474
199. Watson P., Black G., Ramsden S., Barrow M., Super M., Kerr B., et al. Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet 38 (2001) 224-228
200. Wills S., Cabanlit M., Bennett J., Ashwood P., Amaral D., and Van de Water J. Autoantibodies in autism spectrum disorders (ASD). Ann NY Acad Sci 1107 (2007) 79-91
201. Wong P.W., Brackney W.R., and Pessah I.N. Ortho-substituted polychlorinated biphenyls alter microsomal calcium transport by direct interaction with ryanodine receptors of mammalian brain. J Biol Chem 272 (1997) 15145-15153
202. Wong P.W., Garcia E.F., and Pessah I.N. Ortho-substituted PCB95 alters intracellular calcium signaling and causes cellular acidification in PC12 cells by an immunophilin-dependent mechanism. J Neurochem 76 (2001) 450-463
203. Yasui D.H., Peddada S., Bieda M.C., Vallero R.O., Hogart A., Nagarajan R.P., et al. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci USA 104 (2007) 19416-19421
204. Young J.I., Hong E.P., Castle J.C., Crespo-Barreto J., Bowman A.B., Rose M.F., et al. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci USA 102 (2005) 17551-17558
205. Zhang J. Clinical observations in ethyl mercury chloride poisoning. Am J Ind Med 5 (1984) 251-258
206. 3H]ryanodine to rat brain microsomal membranes. Brain Res 561 (1991) 181-191
207. Zimmerman A.W., Connors S.L., Matteson K.J., Lee L.C., Singer H.S., Castaneda J.A., et al. Maternal antibrain antibodies in autism. Brain Behav Immun 21 (2007) 351-357
208. Zoeller R.T. Environmental chemicals impacting the thyroid: targets and consequences. Thyroid 17 (2007) 811-817
209. Zoeller R.T., Dowling A.L., and Vas A.A. Developmental exposure to polychlorinated biphenyls exerts thyroid hormone-like effects on the expression of RC3/neurogranin and myelin basic protein messenger ribonucleic acids in the developing rat brain. Endocrinology 141 (2000) 181-189
210. Zoghbi H.Y. Postnatal neurodevelopmental disorders: meeting at the synapse?. Science 302 (2003) 826-830